- Home
- NERV vs CNFR Comparison
NERV vs CNFR Comparison
Compare NERV & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CNFR
- Stock Information
- Founded
- NERV 2007
- CNFR 2009
- Country
- NERV United States
- CNFR United States
- Employees
- NERV N/A
- CNFR N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CNFR Property-Casualty Insurers
- Sector
- NERV Health Care
- CNFR Finance
- Exchange
- NERV Nasdaq
- CNFR Nasdaq
- Market Cap
- NERV 12.4M
- CNFR 7.9M
- IPO Year
- NERV 2014
- CNFR 2015
- Fundamental
- Price
- NERV $1.59
- CNFR $0.73
- Analyst Decision
- NERV Hold
- CNFR
- Analyst Count
- NERV 1
- CNFR 0
- Target Price
- NERV $5.00
- CNFR N/A
- AVG Volume (30 Days)
- NERV 7.7K
- CNFR 35.2K
- Earning Date
- NERV 05-20-2025
- CNFR 05-13-2025
- Dividend Yield
- NERV N/A
- CNFR N/A
- EPS Growth
- NERV N/A
- CNFR N/A
- EPS
- NERV 0.19
- CNFR 1.92
- Revenue
- NERV N/A
- CNFR $66,771,000.00
- Revenue This Year
- NERV N/A
- CNFR $25.91
- Revenue Next Year
- NERV N/A
- CNFR N/A
- P/E Ratio
- NERV $8.42
- CNFR $0.36
- Revenue Growth
- NERV N/A
- CNFR N/A
- 52 Week Low
- NERV $1.15
- CNFR $0.42
- 52 Week High
- NERV $3.69
- CNFR $1.91
- Technical
- Relative Strength Index (RSI)
- NERV 46.58
- CNFR 56.93
- Support Level
- NERV $1.65
- CNFR $0.69
- Resistance Level
- NERV $1.75
- CNFR $0.77
- Average True Range (ATR)
- NERV 0.08
- CNFR 0.05
- MACD
- NERV -0.00
- CNFR 0.01
- Stochastic Oscillator
- NERV 31.03
- CNFR 84.05
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.